Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy in Dogs with Splenic Hemangiosarcoma.
Sign Up to like & getrecommendations! Published in 2020 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12590
Abstract: We previously reported that eBAT, an EGF-targeted angiotoxin, was safe and improved overall survival for dogs with splenic hemangiosarcoma when added to the standard of care in a single cycle of three administrations in the… read more here.
Keywords: chemotherapy; angiotoxin; splenic hemangiosarcoma; dogs splenic ... See more keywords